NEXA OMT Program

Karla Moon, MSM

Program Director

What is NExA

•  NEXA is a treatment clinic offering OMT (Opioid Maintenance Treatment) since 2006.

•  Our OMT is fully licensed by IDHS/DASA, certified by CSAT, DEA (Drug Enforcement Agency), and CARF International (Certification Accreditation for Rehabilitation Facilities)

•  OMT (Opioid Maintenance Treatment) is a program for individuals with a history of chronic opiate dependence. The treatment options H.A.S. offers for this type of addiction include methadone maintenance treatment (MMT) and suboxone treatment.

What We Do:

•  The OMT program operates at a clinical setting, where methadone serves as a replacement for heroin and other opioids. This program is a long-term program that offers a low cost alternative for treatment in which medical supervision in conjunction with counseling and support has proven effective.

•  Suboxone Pilot Project: Suboxone is a medical alternative for methadone treatment. As a medical alternative, suboxone is available by prescription only for long-term treatment for opioid dependence, it is used in conjunction with a complete treatment plan that includes counseling and support.

The Process: OMT

The Process: Suboxone

Our Participants - Demographics

Our Participants: Gender Breakdown

Employment Challenges

•  The majority of our participants have a low level of education and in the employment market are considered un-skilled

•  The average educational level among participants is up to 10th or 11th grade

•  Most participants have a long history of refusing to follow direction, which is an obstacle to finding stable employment

•  A high number of participants have a criminal background

•  Some participants have low self-esteem

•  Criminal culture or Criminal Thinking (making quick bucks)

Streams Of revenue

•  Client Fees (Cash Collections)

•  Medicaid

•  Chicago Department of Public Health (Ryan White)

•  Aids Foundation of Chicago (Ryan White)

•  Suboxone Project (Prescription Medication subsidized by RICKET Pharmaceutical), Outpatient Treatment by IDOC in conjunction with TASC case management.

Our Challenges

We currently have many participants with high balances, which impacts our cash collections for the program

Our Challenges:

$105,000.00

$110,000.00

$115,000.00

$120,000.00

$125,000.00

$130,000.00

$135,000.00

$140,000.00

FY2008 FY2009 FY2010

 $125,276.70    

 $138,614.00    

119,038.00  

Cash Collections

Cash Collections

Our challenges

$-

$2,000.00

$4,000.00

$6,000.00

$8,000.00

$10,000.00

$12,000.00

$14,000.00

July August September October November

$11,465.00 $11,397.00 $11,998.00 12,047.00

10,189.00

6,198.00 7,016.00

6,334.00

7,772.00

5,968.00

Cash Collection Comparison

FY09

FY10

Our Challenges

•  Sub-Culture:

a)  Because of the long lasting length of the treatment process, many participants have developed a connection and know the “system”

b)  Some participants manipulate the “system”, this is challenging in our cash collection process

Our Challenges

•  Stigma: Stigma refers to the negative attitudes (prejudice) and negative behavior (discrimination) toward people with substance use and mental health problems.

a)  In order to address this stigma SAMHSA has adopted new terminology for this type of treatment: MAT (Medication-Assisted Treatment)

b)  Add something about how stigma affects people attaining a job,

c)  MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to treatment.

Opportunities

•  Expand baseline of private participants and reach out to health insurance networks (We have a contract with value options)

•  Expand and enhance MAT (suboxone treatment) to other areas in the city. (A better facility will facilitate this process)

•  Market MAT as an option for pain management

•  Continue Increasing Medicaid referrals by reaching out to population in need for services

•  Continue looking for public funding

•  Expand Specialized MAT treatment for Criminal Justice population